[Swiss clinical practice guidelines for skin cancer in organ transplant recipients].
Swiss clinical practice guidelines for skin cancer in organ transplant recipients Transplant patients have increased over the last decades. As a consequence of long-term immunosuppression, skin cancer, in particular squamous cell carcinoma (SCC), has become an important problem. Screening and education of potential organ transplant recipients (OTRs) regarding prevention of sun damage and early recognition of skin cancer are important before transplantation. Once transplanted, OTRs should be seen yearly by a dermatologist to ensure compliance with sun avoidance as well as for treatment of precancerosis and SCC. Early removal is the best treatment for SCC. Reduction of immunosuppression, switch to mTOR inhibitors and chemoprevention with acitretin may reduce the incidence of SCC. The dermatological follow-up of OTRs should be integrated into a comprehensive post-transplant management strategy.
Lapointe
A-K
AK
Service de dermatologie et vénéréologie, CHUV, Lausanne. Anne-Carine.Lapointe@chuv.ch
Hofbauer
G
G
Anliker
M
M
Arnold
A
A
Binet
I
I
Hunger
R
R
Kempf
W
W
Pascual
M
M
Pelloni
F
F
Serra
A
A
Laffitte
E
E
D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016377:Organ Transplantation; D017410:Practice Guidelines as Topic; D012878:Skin Neoplasms / Q000517:prevention & control*; D013557:Switzerland
D007166:Immunosuppressive Agents